Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study
NCT03152097
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Kidney Diseases
Cardiovascular Diseases
Interventions
DIETARY_SUPPLEMENT:
Commercially available Diindolylmethane
OTHER:
Placebo
Sponsor
University of Pittsburgh